To test our hypothesis, BEAS-2B cells were treated with Golgicide A to artificially induce Golgi fragmentation, prior to infection with Spn. Successful Golgi disruption and unaffected cell viability was confirmed by immunofluorescence microscopy and MTT assay (Figure S3). The gene discussed is SPN; the disease is infection.